Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
Clinical trial NCT05791409 · RECRUITING
Trial details
- NCT number
- NCT05791409
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2029-03-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.